COPIED
3 mins

ADVERTORIAL

5 MINUTES WITH ... IAIN DE HAVILLAND

Founder of NADclinic Group, Iain De Havilland discusses evolution of NAD+ therapy and the growing role of personalised longevity medicine in aesthetics.

WHAT FIRST INTRODUCED YOU TO NAD+?

“I first came across NAD+ through its use in addiction and detox medicine. I became convinced that its relevance could extend far beyond the very narrow context in which it was then being used.

“We launched NADclinic in 2016 with a fairly simple belief that the science pertaining to NAD+ therapy deserved a much bigger conversation. The opportunity was never just to build an IV clinic. It was to take something highly specialised, apply proper standards, education and clinical thinking around it, and explore how NAD+ could fit into a much broader model of longevity, resilience and human performance.”

WHAT IS DRIVING THE INTEREST?

“People do not want to wait until something goes wrong. They want to understand their biology earlier, maintain their energy and resilience, recover better and remain physically and cognitively capable for longer.

“NAD+ fits naturally into that conversation because it is fundamental to cellular metabolism and plays an important role in energy production and wider cellular processes. “Aesthetics is experiencing exactly the same evolution. The conversation is moving from simply treating what we can see on the outside towards understanding the biology underneath it.”

WHAT IS NAD’S ROLE IN THE BODY?

“I normally describe NAD+ as part of the body’s cellular energy infrastructure. Every cell depends on it. It plays an essential role in the reactions that allow nutrients to be converted into usable cellular energy, while also participating in pathways involving DNA repair, cellular signalling and stress responses.

“That biological importance is why researchers are studying NAD metabolism across ageing, metabolic health, neurological function, muscle health and other areas. But we also need to distinguish exciting biology from established clinical outcomes. There is strong mechanistic science around NAD+, while human outcome data are still developing and vary depending on the intervention and route of delivery.”

HOW HAS THE NADCLINIC EVOLVED?

“Since launching in 2016 with NAD+, NADclinic Group has expanded into more than 40 countries, working with leading clinicians, medical and aesthetic clinics, hospitality groups, professional sport and wellness organisations, while developing advanced diagnostics, delivery systems and performance medicine platforms.

“The biggest evolution has been philosophical. We have moved from intervention to infrastructure. Products matter, but so do education, manufacturing quality, diagnostics, clinical governance, distribution and the people making the decisions.”

HOW DO YOU ENSURE TREATMENTS ARE GROUNDED IN SCIENTIFIC EVIDENCE?

“Innovation is exciting, but innovation without discipline eventually damages an industry.

“Our approach starts with quality of product, manufacturing standards, sterility where applicable, batch traceability, documentation and appropriate clinical oversight.

“We also try to be very disciplined about language. A promising mechanism is not the same thing as a proven clinical outcome. Animal data are not human data. An interesting biomarker does not automatically translate into a meaningful patient benefit.”

“Longevity has sometimes moved faster commercially than the evidence underneath it. Our philosophy is straightforward: Push innovation hard, but never lower the bar to do it.”

WHAT SHOULD CLINICS CONSIDER BEFORE INTRODUCING NAD+ THERAPIES?

“My first advice would be: do not simply add NAD+ to a treatment menu because patients are asking for it.

“Understand what you are offering and why, starting with appropriate patient assessment, medical history, medications, contraindications and a clear conversation around expectations. It then extends to product provenance, formulation, sterility, storage, administration protocols, clinical training, monitoring and aftercare.

“The practitioner also needs to understand where NAD+ sits within the patient’s wider picture. At NADclinic we increasingly favour a measure first, intervene intelligently, measure again philosophy. The future patient may not see skin, hormones, metabolism, recovery and longevity as completely separate conversations.”

WHAT DO YOU BELIEVE THE NEXT CHAPTER OF NAD+ WILL LOOK LIKE?

“The next chapter is integration. Diagnostics will establish a baseline. AI and longitudinal data will help identify patterns. Clinicians will interpret that information. Nutrition, movement, sleep and strength remain the foundations, while interventions such as NAD+, metabolic medicines, hormonal optimisation, regenerative therapies and more sophisticated peptide strategies sit around them where appropriate. And then we measure again.

“Aesthetics has historically been brilliant at treating the visible expression of ageing. Longevity medicine asks what is happening underneath it.

“I believe the next generation of great aesthetic clinics will increasingly understand both. Not simply helping people look younger, but helping them remain biologically resilient, metabolically healthy and capable for longer.”

This article is sponsored by NAD Clinic

This article appears in Nov/dec 2026

Go to Page View
This article appears in...
Nov/dec 2026
Go to Page View
DEAR READERS
There’s always something new to talk about in
MEET THE EXPERTS
The Aesthetic Medicine editorial board’s clinical expertise and diverse range of specialities help ensure the magazine meets the needs of the readers. In this issue, we have received guidance from the following members:
SKIN QUALITY REDEFINED
As skin quality becomes an increasingly prominent focus in aesthetic practice, Teoxane introduces babyGLOW™ and babyGLOW™ for HIM, two protocols designed to address skin revitalisation with a focus on precision and natural-looking results. 1
HOT OFF THE PRESS
UK government launches consultation on high-risk cosmetic procedures
OUT & ABOUT
REJURAN PRESS TRIP Seoul and Gangneung, South Korea
JEN VITTANUOVA IS… LEGALLY AESTHETIC
Funny, frank and fiercely attached to her patients, Jen Vittanuova is bringing her experience as an aesthetic nurse and expert witness into education. With Legally Blonde as her muse, she is making the case for better consent, sharper records and safer clinics, discovers Kezia Parkins .
CASE STUDY: CHRONIC ACNE AND SCARRING TRANSFORMATION
Treating chronic acne and post-acne concerns with a personalised combination approach
PDRN VS PN: WHAT AESTHETIC PRACTITIONERS NEED TO KNOW
As PDRN moves into topical skincare and injectable polynucleotides gain prominence in clinics, confusion surrounding the two categories is growing. Ellen Cummings examines their proposed mechanisms, evidence and implications for clinical practice.
BEYOND THE SURFACE
A multi-layer approach to skin rejuvenation with RF Microneedling
NEXT UP
Claudia McGloin asks: what should really define the next trend in regenerative injectables?
THE EVOLVING BOOB JOB
Consultant plastic surgeon Paul Banwell on awake surgery, tissue preservation, implant innovation and the future of the “boob job”.
BEYOND THE TEMPLATE
Dr Ahmed El Muntasar argues that safe, individualised aesthetic care requires practitioners to understand anatomical variation, assess skin characteristics and question whose beauty standards shape treatment.
CLINIC TO COSMETIC COUNTER
Dr Farah Latif and Prof Ali Al -Hussaini ask: are professional treatments becoming beauty products?
UNDERSTANDING ICHTHYOSIS VULGARIS
Dr Kemi Fabusiwa and Professor Edel O’Toole explain how to recognise, manage and treat ichthyosis vulgaris, from protecting the skin barrier to supporting patients with long-term care.
RETHINKING THE RESEARCH
Dr Jordan Faulkner on why practitioners need to question the evidence behind the treatments they offer.
PRACTICALLY PERFECT?
As Practical Magic 2 hits cinemas, 28 years after the original, its female stars have ignited a debate around ageing: don’t have too much work done, but don’t show any signs of ageing. Vicky Eldridge asks: how can women in aesthetic medicine help to change the narrative?
PRECISION FIRST
Emma Wedgwood looks into why the next big thing in 2027 will not be a treatment, but precision.
WHEN TRENDS TRAVEL FASTER than governance
From glass skin to treatment stacking, South Korea is shaping patient expectations. But does faster adoption mean better practice? Jen Vittanuova explores what UK aesthetics can learn, and why clinical judgement must keep pace with innovation.
THE UNSEEN WORK OF EXCELLENCE
Why clinical excellence depends on consistent standards, practical experience and knowing when to keep learning.
THE PURSUIT OF EXPERTISE OR THE PURSUIT OF RECOGNITION?
Amy Bird questions whether aesthetic medicine is prioritising visibility and recognition over clinical knowledge.
LEAD WITH THE CONDITION NOT THE CURE
Why condition-led websites win more consultations and keep you on the right side of the ASA.
ASK THE EXPERTS
Which health factors could influence treatment outcomes?
THE INTELLIGENT CLINIC
Dr Askari Townshend looks into why the future of aesthetics will be driven by data.
HOW AI SEARCH IS CHANGING WHERE PATIENTS FIND AESTHETIC CLINICS
AI is changing how patients discover aesthetic clinics. Panita Vig explains what AI search means for clinic visibility and the practical steps practitioners can take now to stay discoverable.
RETHINKING CLINICAL STYLE
Ditching the traditional clinical look, Emma Wedgwood shares how she transformed her treatment room into a space that reflects her style and personality.
PROTECT YOUR PRACTICE
Asking the right questions now can help protect your practice, reputation and clients later,
HYDRAFACIAL NANO-NEEDLING
Connie Cooper visited the Hydrafacial flagship to try their latest treatment: Hydrafacial Deluxe with SkinStylus Nano-Needling.
DOUBLE CHIN TIGHTENING WITH XERF
Contributing reporter Anna Dobbie visits the Seriderm Training Centre to experience XERF, a non-invasive radiofrequency treatment that tightens and firms the skin beneath her chin.
PRODUCT NEWS
AlumierMD AlumierMD has expanded its Biocellulose range with
5 MINUTES WITH ... IAIN DE HAVILLAND
Founder of NADclinic Group, Iain De Havilland discusses evolution of NAD+ therapy and the growing role of personalised longevity medicine in aesthetics.
5 ANATOMY EXPERTS TO FOLLOW
These five specialists are putting facial anatomy, clinical knowledge and education at the forefront of aesthetics.
Looking for back issues?
Browse the Archive >

Previous Article Next Article